tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market
AVTX
Avalo Therapeutics
RESEARCH TOOLSreports

Avalo Therapeutics (AVTX) Stock News & Sentiment

1,050 Followers
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
18d ago
AVTX
Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout
Premium
Ratings
Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout
18d ago
AVTX
De-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
Premium
Ratings
De-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
3M ago
AVTX
Avalo Therapeutics Highlights AVTX-009 Progress in HS
Premium
Company Announcements
Avalo Therapeutics Highlights AVTX-009 Progress in HS
3M ago
8K
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
Premium
Company Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
4M ago
8K
AVTX
Avalo Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Avalo Therapeutics Reports Q3 2025 Financial Results
5M ago
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
Premium
Company Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
5M ago
8K
AVTX
More AVTX News >

AVTX News on the Web

Avalo Therapeutics initiated with an Outperform at Wolfe Research
TipRanks News
Bullish
Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics
Zacks
Bullish
Avalo Therapeutics initiated with an Outperform at Citizens
TipRanks News
Bullish
Insider Sell Alert: Christopher Sullivan Sells Shares of Avalo Therapeutics Inc (AVTX)
GuruFocus News
Neutral
Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's What You Should Know
Zacks
Bullish
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
Zacks
Neutral
Piper Sandler Keeps Their Buy Rating on Avalo Therapeutics (AVTX)
TipRanks News
Bearish
CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer
Zacks
Bearish

News Score - Last 7 Days

Very Positive
AVTX
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AVTX’s Media Buzz Sentiment?
3 articles about AVTX were published this week. In an average week, 3.75 articles are published.
    What is AVTX’s weekly average amount of articles?
    In an average week, 3.75 articles about AVTX are published.
      What is AVTX’s News Sentiment?
      100% of articles about AVTX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week